SYNTEX PHARMA LTD has a total of 46 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are LEAD DISCOVERY CENTER GMBH, ANGIBAUD PATRICK RENE and YING WEIWEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | New Zealand | 3 | |
#5 | South Africa | 3 | |
#6 | Australia | 2 | |
#7 | Denmark | 2 | |
#8 | Finland | 2 | |
#9 | Hungary | 2 | |
#10 | Ireland | 2 | |
#11 | Philippines | 2 | |
#12 | Brazil | 1 | |
#13 | China | 1 | |
#14 | Israel | 1 | |
#15 | Republic of Korea | 1 | |
#16 | Mexico | 1 | |
#17 | Norway | 1 | |
#18 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Pascal Jean-Claude | 24 |
#2 | Lee Chi-Ho | 21 |
#3 | Pinhas Henri | 19 |
#4 | Alps Brian J | 18 |
#5 | Whiting Roger L | 18 |
#6 | Mccort Gary | 12 |
#7 | Beranger Serge | 11 |
#8 | Blondet Dominique | 9 |
#9 | Pascal Jean C | 7 |
#10 | Gellibert Francoise | 7 |
Publication | Filing date | Title |
---|---|---|
US5428037A | Heterocyclic derivatives in the treatment of Ischaemia and related diseases | |
US5296609A | Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives | |
US5252736A | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives | |
US5091428A | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives | |
US5063220A | Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine | |
PH27405A | Process for the preparation of substituted imidazolyl-alkyl-piperazine and diazepine derivatives | |
US5010075A | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives | |
US4935417A | Sustituted imidazolyl-alkyl-piperazine and -diazepine derivatives for treating cerebrovascular disease | |
US5043447A | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives | |
US4973591A | Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine | |
US4829065A | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |